Showing results (1621-1630 of 1,662) with videos related to

Sort By:
Pageof 167
Proteomics|April 15, 2010
A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's diseaseVictoria M Perreau, Sandra Orchard, Paul A Adlard, et al.
Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.
JAMA Oncology|October 23, 2018
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical TrialGerald Falchook, Robert L Coleman, Andrzej Roszak, et al.
Lancet (London, England)|May 13, 2014
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialSéverine Vermeire, Sharon O'Byrne, Mary Keir, et al.
Pilot and Feasibility Studies|February 17, 2024
Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trialGareth Jones, Laura Bailey, Rebecca J Beeken, et al.
JCI Insight|July 1, 2016
Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase πDavid H McMillan, Jos Lj van der Velden, Karolyn G Lahue, et al.
JAMA Cardiology|April 22, 2026
Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T AssayAlexander J F Thurston, Yong Yong Tew, Pedro Lopez-Ayala, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 28, 2025
Living donor uterus transplant research project in Singapore: Progress of the first caseHak Koon Tan, Terence Y S Kee, Bien Keem Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Gynecologic Oncology|May 6, 2023
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary studyTiffany Y Sia, William P Tew, Christopher Purdy, et al.
Pageof 167